{"entity":{"type":"insider","cik":"0001673802","url":"/insider/0001673802","json_url":"/insider/0001673802.json","name":"Ros Matthew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2018-02-06","last":"2021-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Ros Matthew","source":"filing","n_filings":8,"first_seen":"2018-02-06","last_seen":"2021-02-05"}],"transactions":[{"id":4811335,"accession":"0000899243-21-005033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-005033","line_url":"/filing/0000899243-21-005033#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":894.0,"shares_display":"894","price_per_share":11.21,"price_display":"11.21","price_state":"stated","total_value":10021.74,"total_display":"10,021.74","total_whole":"10,022","shares_owned_after":83188.0,"shares_owned_after_display":"83,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":5454761,"accession":"0000899243-21-003533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-003533","line_url":"/filing/0000899243-21-003533#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2872.0,"shares_display":"2,872","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":32769.52,"total_display":"32,769.52","total_whole":"32,770","shares_owned_after":55957.0,"shares_owned_after_display":"55,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":2632593,"accession":"0000899243-20-017900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017900","line_url":"/filing/0000899243-20-017900#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2728.0,"shares_display":"2,728","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":44057.2,"total_display":"44,057.20","total_whole":"44,057","shares_owned_after":57507.0,"shares_owned_after_display":"57,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-30","scope":"insider"},{"id":2731967,"accession":"0000899243-20-017434","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-017434","line_url":"/filing/0000899243-20-017434","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112003.0,"shares_display":"112,003","price_per_share":21.235535208878332,"price_display":"21.24","price_state":"stated","total_value":2378443.65,"total_display":"2,378,443.65","total_whole":"2,378,444","shares_owned_after":51798.0,"shares_owned_after_display":"51,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider","n_lines":3},{"id":3309532,"accession":"0000899243-20-009606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-009606","line_url":"/filing/0000899243-20-009606#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1243.0,"shares_display":"1,243","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":18993.04,"total_display":"18,993.04","total_whole":"18,993","shares_owned_after":51798.0,"shares_owned_after_display":"51,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-26","scope":"insider"},{"id":2039416,"accession":"0000899243-20-002114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-002114","line_url":"/filing/0000899243-20-002114#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1847.0,"shares_display":"1,847","price_per_share":24.64,"price_display":"24.64","price_state":"stated","total_value":45510.08,"total_display":"45,510.08","total_whole":"45,510","shares_owned_after":42185.0,"shares_owned_after_display":"42,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-24","filed_date":"2020-01-27","scope":"insider"},{"id":8608547,"accession":"0000899243-19-017099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-017099","line_url":"/filing/0000899243-19-017099#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1185.0,"shares_display":"1,185","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":14338.5,"total_display":"14,338.50","total_whole":"14,339","shares_owned_after":39032.0,"shares_owned_after_display":"39,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-14","scope":"insider"},{"id":6330925,"accession":"0001209191-18-007843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-007843","line_url":"/filing/0001209191-18-007843","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001673802","owner_name":"Ros Matthew","owner_display_name":"Ros Matthew","owner_url":"/insider/0001673802","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72264.0,"shares_display":"72,264","price_per_share":16.629228931418133,"price_display":"16.63","price_state":"stated","total_value":1201694.5995,"total_display":"1,201,694.60","total_whole":"1,201,695","shares_owned_after":3122.0,"shares_owned_after_display":"3,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-06","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer","n_filings":8,"first_seen":"2018-02-06","last_seen":"2021-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673802","retrieved_at":"2026-08-27T02:50:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}